Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Tango Therapeutics (TNGX) EPS (Basic): 2020-2024

Historic EPS (Basic) for Tango Therapeutics (TNGX) over the last 5 years, with Dec 2024 value amounting to -$1.19.

  • Tango Therapeutics' EPS (Basic) rose 151.85% to $0.14 in Q3 2025 from the same period last year, while for Sep 2025 it was -$0.91, marking a year-over-year increase of 21.55%. This contributed to the annual value of -$1.19 for FY2024, which is 10.19% down from last year.
  • According to the latest figures from FY2024, Tango Therapeutics' EPS (Basic) is -$1.19, which was down 10.19% from -$1.08 recorded in FY2023.
  • In the past 5 years, Tango Therapeutics' EPS (Basic) ranged from a high of -$0.94 in FY2021 and a low of -$1.63 during FY2020.
  • In the last 3 years, Tango Therapeutics' EPS (Basic) had a median value of -$1.19 in 2024 and averaged -$1.17.
  • Per our database at Business Quant, Tango Therapeutics' EPS (Basic) soared by 42.33% in 2021 and then plummeted by 30.85% in 2022.
  • Over the past 5 years, Tango Therapeutics' EPS (Basic) (Yearly) stood at -$1.63 in 2020, then spiked by 42.33% to -$0.94 in 2021, then tumbled by 30.85% to -$1.23 in 2022, then grew by 12.20% to -$1.08 in 2023, then dropped by 10.19% to -$1.19 in 2024.